HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Amando Gamba Amedeo Terzi Paolo Ferrazzi Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gamba, A. Articles by Ferrazzi, P. Search for Related Content PubMed PubMed Citation Articles by Gamba, A. Articles by Ferrazzi, P. Related Collections Transplantation - heart

J Thorac Cardiovasc Surg 2004;127:555-562
© 2004 The American Association for Thoracic Surgery

Cardiothoracic transplantation

Heart transplantation in patients with previous Fontan operations

^a Departments of Cardiovascular Surgery, Ospedali Riuniti di Bergamo, Bergamo, Italy

Received for publication April 16, 2003; revisions received June 20, 2003; accepted for publication August 1, 2003.

^* Address for reprints: Amedeo Terzi, U.O. Cardiochirurgia, Ospedali Riuniti di Bergamo, Largo Barozzi 1, Bergamo 24100, Italy
terzia{at}cyberg.it

OBJECTIVE: The clinical features and outcomes of patients undergoing heart transplantation after a failed Fontan operation are still debated. The aim of this study was to retrospectively evaluate our experience in 14 patients undergoing heart transplantation after previous Fontan-type operations.

METHODS: From 1990 to 2002, 14 patients underwent heart transplantation in our institution after a previous Fontan procedure. The mean age at the time of the Fontan operation and at transplantation was 7.3 ± 2.8 and 17.2 ± 6.3 years, respectively. The indication for transplantation was protein-losing enteropathy in 7 patients, arrhythmia with ventricular dysfunction in 5 patients, and heart failure in 2 patients. All patients received basic immunosuppressive therapy with cyclosporine (INN: ciclosporin) and azathioprine without induction therapy or maintenance steroids.

RESULTS: Two hospital deaths occurred: one patient died on the fifth postoperative day of graft failure, and the second died on the 17th postoperative day after an acute neurologic event. Two patients died later, one 23 months after transplantation of acute rejection and the other after 90 months of chronic rejection and endocarditis. One patient underwent successful reintervention 2 years after heart transplantation for pulmonary vein obstruction. The 10 surviving patients are in New York Heart Association class I, with a mean follow-up of 64.5 ± 42 months. One of them was delivered of a healthy baby 5 years after transplantation. Patients with protein-losing enteropathy reached a normal protein level within a mean of 10 months (range, 6-18 months) after transplantation. Four patients required a temporary administration (3-6 months) of oral steroid therapy for recurrent rejection episodes. Currently, 7 patients are taking cyclosporine, and 3 are taking cyclosporine and azathioprine. The actuarial survival at 1, 5, and 10 years was 86% ± 9%, 77% ± 12%, and 62% ± 17%, respectively.

CONCLUSION: Heart transplantation is a good option for patients with a failing Fontan operation. We documented the reversibility of protein-losing enteropathy in all patients. No mortality caused by surgical complications was observed.

This article has been cited by other articles:

				H. Laks, D. Marelli, M. Plunkett, and J. Myers Adult Congenital Heart Disease Card. Surg. Adult, January 1, 2008; 3(2008): 1431 - 1464. [Full Text]

				C. S.D. Almond, J. E. Mayer Jr, R. R. Thiagarajan, E. D. Blume, P. J. del Nido, and D. B. McElhinney Outcome After Fontan Failure and Takedown to an Intermediate Palliative Circulation Ann. Thorac. Surg., September 1, 2007; 84(3): 880 - 887. [Abstract] [Full Text] [PDF]

				A.-R. Hosseinpour, S. Cullen, and V. T. Tsang Transplantation for adults with congenital heart disease. Eur. J. Cardiothorac. Surg., September 1, 2006; 30(3): 508 - 514. [Abstract] [Full Text] [PDF]

				A. M. Ostrow, H. Freeze, and J. Rychik Protein-Losing Enteropathy After Fontan Operation: Investigations Into Possible Pathophysiologic Mechanisms Ann. Thorac. Surg., August 1, 2006; 82(2): 695 - 700. [Abstract] [Full Text] [PDF]

				D. Bernstein, D. Naftel, C. Chin, L.J. Addonizio, P. Gamberg, E.D. Blume, D. Hsu, C.E. Canter, J.K. Kirklin, W.R. Morrow, et al. Outcome of Listing for Cardiac Transplantation for Failed Fontan: A Multi-Institutional Study Circulation, July 25, 2006; 114(4): 273 - 280. [Abstract] [Full Text] [PDF]

				I. A. Russell, K. Rouine-Rapp, G. Stratmann, and W. C. Miller-Hance Congenital heart disease in the adult: a review with internet-accessible transesophageal echocardiographic images. Anesth. Analg., March 1, 2006; 102(3): 694 - 723. [Full Text] [PDF]

				M. Chaudhari, J. Sturman, J. O'Sullivan, J. Smith, N. Wrightson, G. Parry, D. Bolton, S. Haynes, L. Hamilton, and A. Hasan Rescue cardiac transplantation for early failure of the Fontan-type circulation in children J. Thorac. Cardiovasc. Surg., February 1, 2005; 129(2): 416 - 422. [Abstract] [Full Text] [PDF]

				M. B. Mitchell, D. N. Campbell, D. Ivy, M. M. Boucek, H. M. Sondheimer, B. Pietra, B. B. Das, and J. R. Coll Evidence of pulmonary vascular disease after heart transplantation for Fontan circulation failure J. Thorac. Cardiovasc. Surg., November 1, 2004; 128(5): 693 - 702. [Abstract] [Full Text] [PDF]